ROBINSON, KEITH D.O.
Dermatology · NPI 1174704183 · DANVILLE, VA
ROBINSON, KEITH is a Dermatology in DANVILLE, VA, a member of 1 medical group, who billed 32 distinct codes to Medicare Part B in 2024.
Groups: COMPLEXIONS DERMATOLOGY, PC (DANVILLE, VA)
Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒
Provider overview · all codes · CY2024
All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.
Procedures billed to Medicare Part B (2024)
Medicare Part B FFS · CY2024 · as published by CMS| Code | Description | Services | Beneficiary-episodes | Avg charge | Avg Medicare payment |
|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | premium | premium | premium | premium |
| 17003 | Destruction of precancer skin growth, 2-14 growths | premium | premium | premium | premium |
| 17000 | Destruction of precancer skin growth, 1 growth | premium | premium | premium | premium |
| 11102 | Biopsy of related skin growth, first growth | premium | premium | premium | premium |
| 99203 | New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 99212 | Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more | premium | premium | premium | premium |
| 17110 | Destruction of skin growth, 1-14 growths | premium | premium | premium | premium |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | premium | premium | premium | premium |
| 11103 | Biopsy of related skin growth, each additional growth | premium | premium | premium | premium |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | premium | premium | premium | premium |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | premium | premium | premium | premium |
| 11104 | Punch biopsy, first skin growth | premium | premium | premium | premium |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | premium | premium | premium | premium |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | premium | premium | premium | premium |
| 99202 | New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more | premium | premium | premium | premium |
| 10060 | Simple or single drainage of skin abscess | premium | premium | premium | premium |
| 69100 | Biopsy of ear | premium | premium | premium | premium |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | premium | premium | premium | premium |
| 17004 | Destruction of precancer skin growth, 15 or more growths | premium | premium | premium | premium |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | premium | premium | premium | premium |
| 11900 | Injection into skin growth, 1-7 growths | premium | premium | premium | premium |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | premium | premium | premium | premium |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | premium | premium | premium | premium |
| 99204 | New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | premium | premium | premium | premium |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | premium | premium | premium | premium |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | premium | premium | premium | premium |
| 96372 | Injection of drug or substance under skin or into muscle | premium | premium | premium | premium |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | premium | premium | premium | premium |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | premium | premium | premium | premium |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | premium | premium | premium | premium |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | premium | premium | premium | premium |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | premium | premium | premium | premium |
These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.